1. Adlercreutz, H., Gorbach, S. L., Goldin, B. R., Woods, M. N., Dwyer, J. T., and Hamalainen, E. (1994). Estrogen metabolism and excretion in oriental and Caucasian women. J. Natl. Cancer Inst.86,1076–1082.
2. Bhat, K. P., Lantvit, D., Christov, K., Mehta, R. G., Moon, R. C., and Pezzuto, J. M. (2001). Estrogenic and antiestrogenic properties of resveratrol in mammary tumour models. Cancer Res.61,7456–7463.
3. Chen, S., Zhou, D., Okubo, T., Kao, Y.-C., and Yang, C. (1999). Breast tumor aromatase: Functional role and transcriptional regulation. Endocr. Relat. Cancer6,149–156.
4. Ciolino, H. P., and Yeh, G. C. (1999). Inhibition of aryl hydrocarbon-induced cytochrome p-450 1A1 enzyme activity and CYP1A1 expression by resveratrol. Mol. Pharmacol.56,760–767.
5. Colditz, G. A. (1999). Hormones and breast cancer: Evidence and implications for consideration of risks and benefits of hormone replacement therapy. J. Womens Health8,347–357.